SCHEMBL30718459

SCHEMBL30718459

O=C(OCc1ccc(F)cc1)c1ccc2c(c1)CCCN2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
KDM4E B2RXH2 2/20 0.54
ACHE P22303 4/20 0.45
NR4A2 P43354 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAOB P27338 4/20 0.41
PARP10 Q53GL7 1/20 0.41
MAOA P21397 1/20 0.41
GAA P10253 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP12 P39900 1/20 0.41
MASP2 O00187 1/20 0.40
F2 P00734 1/20 0.40
NPC1 O15118 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30955004 0.88 MAPT (0.60) MAPTKDM4EACHEKMT2AMAOB
SCHEMBL16585812 0.88 MAPT (0.60) MAPTKDM4EACHEKMT2AMAOB
SCHEMBL20074352 0.80 KMT2A (0.53) MAPTKDM4EACHEKMT2AMAOB
SCHEMBL30853462 0.80 MAPT (0.62) MAPTKDM4EACHEMEN1KMT2A
SCHEMBL4682191 0.80 MAPT (0.62) MAPTKDM4EACHEMEN1KMT2A
SCHEMBL27370813 0.79 KDM4E (0.54) MAPTKDM4EACHEMASP2F2
SCHEMBL21612896 0.78 ACHE (0.52) MAPTKDM4EACHEKMT2ANPC1
SCHEMBL30954999 0.78 ACHE (0.52) MAPTKDM4EACHEKMT2ANPC1
SCHEMBL45146 0.75 MAPT (0.68) MAPTKDM4EACHEMEN1KMT2A
SCHEMBL29995197 0.75 MAPT (0.68) MAPTKDM4EACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4547247-A2 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF Dana-Farber Cancer Institute, Inc. (US) 2025-05-07 EP disclosed
WO-2024006956-A9 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-04-11 WO disclosed
WO-2024006956-A2 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-01-04 WO disclosed